Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2017 Feb 1;21(2):167–174. doi: 10.5588/ijtld.16.0493

Table 1.

MDR-TB patients who started MDR-TB treatment and patients who initiated BDQ treatment, per country, 2015

Country Estimated number of laboratory-confirmed MDR-TB patients in country in 2015* Laboratory-confirmed MDR-TB patients in country in 2015*
n
MDR-TB patients initiated on treatment in 2015
n
MDR-TB patients started on BDQ in 2015
n
Estimated proportion of treated patients started on BDQ
%
Belarus 1710 1282 1949 138 7.1
France 56 111 98 45 45.9
Georgia 640 441 466 128 27.5
South Africa 6200 18 734 12 516 1085 8.6
Swaziland 460 358 483 30 6.2
*

Estimates are based on WHO modeling and include very wide confidence intervals; there may thus be more individuals diagnosed with MDR-TB than the estimates. Of note, there may in some countries be more persons started on MDR-TB treatment than those with confirmed MDR-TB from that year because persons with extra-pulmonary disease, children, close contacts, and others may be started on treatment empirically even in the absence of culture confirmation.

MDR-TB = multidrug-resistant tuberculosis; BDQ = bedaquiline; WHO = World Health Organization.